The Singapore entity of Sydney-headquartered clinical research and testing company Novotech Health has allotted new shares worth $5 million to US-based NCGS Inc, according to corporate filings reviewed by DealStreetAsia – DATA VANTAGE.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
